EGFR anticorps (Extracellular Domain)
(2 références)Aperçu rapide pour EGFR anticorps (Extracellular Domain) (ABIN2473405)
Antigène
Voir toutes EGFR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- Extracellular Domain
-
Attributs du produit
- Purified IgG
-
Purification
- Purified
-
Immunogène
- Extracellular domain of human EGF-receptor from head and neck carcinoma
-
Isotype
- IgG2a
-
-
anti-Epidermal Growth Factor Receptor (EGFR) (AA 693-893) antibody
EGFR Reactivité: Humain WB, IHC, ELISA, FACS Hôte: Souris Monoclonal 7A6F12 unconjugated
anti-Epidermal Growth Factor Receptor (EGFR) (AA 888-1210) antibodyEGFR Reactivité: Humain WB, IHC Hôte: Souris Monoclonal C4 unconjugated
anti-Epidermal Growth Factor Receptor (EGFR) (AA 1163-1191), (C-Term) antibodyEGFR Reactivité: Humain WB, IHC (p) Hôte: Souris Monoclonal 688CT33-1-3 unconjugated
anti-Epidermal Growth Factor Receptor (EGFR) (C-Term) antibodyEGFR Reactivité: Humain, Souris, Rat, Porc, Singe, Boeuf (Vache), Poulet, Chien, Cheval, Lapin, Cobaye, Avian, Cat, Âne, Chévre, Hamster, Mouton WB Hôte: Chèvre Polyclonal unconjugated
anti-Epidermal Growth Factor Receptor (EGFR) (AA 693-893) antibodyEGFR Reactivité: Humain WB, ELISA, FACS Hôte: Souris Monoclonal 5E10D3 unconjugated
anti-Epidermal Growth Factor Receptor (EGFR) (pSer1071) antibodyEGFR Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-Epidermal Growth Factor Receptor (EGFR) (pSer695) antibodyEGFR Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-Epidermal Growth Factor Receptor (EGFR) (pSer1026) antibodyEGFR Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-Epidermal Growth Factor Receptor (EGFR) (C-Term) antibodyEGFR Reactivité: Humain, Rat WB, IHC, ELISA, IP Hôte: Lapin Polyclonal unconjugated
anti-Epidermal Growth Factor Receptor (EGFR) (AA 888-1210) antibodyEGFR Reactivité: Humain WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.0 mg/mL
-
-
-
: "The receptor for EGF and its ligands - expression, prognostic value and target for therapy in cancer (review)." dans: International journal of oncology, Vol. 4, Issue 2, pp. 277-96, (2011) (PubMed).
: "Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin." dans: Cancer research, Vol. 70, Issue 5, pp. 2030-40, (2010) (PubMed).
-
: "The receptor for EGF and its ligands - expression, prognostic value and target for therapy in cancer (review)." dans: International journal of oncology, Vol. 4, Issue 2, pp. 277-96, (2011) (PubMed).
-
- EGFR (Epidermal Growth Factor Receptor (EGFR))
-
Autre désignation
- EGF R
-
Sujet
- Synonyms: EPIDERMAL GROWTH FACTOR RECEPTOR
-
ID gène
- 1956
-
UniProt
- P00533
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Stem Cell Maintenance, Hepatitis C, Positive Regulation of Response to DNA Damage Stimulus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation, S100 Proteins
Antigène
-
